Genentech's Lucentis Gains FDA Approval For Macular Edema, Expands Market Opportunity
This article was originally published in The Pink Sheet Daily
Executive Summary
Genentech's Lucentis is now approved to treat macular edema following retinal vein occlusion, in addition to wet eye macular degeneration.